Rhythm Pharmaceuticals, Inc. RYTM
9 trading plans running, 15 Form 144 notices for $46.2M
10-Q, 10-K and Form 144What RYTM's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Dec 15, 2025 to Feb 1, 2028. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| David Meeker Chief Executive Officer |
Ended 10b5-1 plan | Sep 18, 2026 | 10-Q Nov 3, 2026 | ||
What the company wroteOn September 18, 2026 , David Meeker, the Company's Chief Executive Officer, terminated a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, which was previously adopted on June 15, 2026 and provided for the sale of up to 300,000 shares of the Company's common stock until March 15, 2027. | |||||
| Alastair Garfield Chief Scientific Officer |
Adopted 10b5-1 plan | Sep 9, 2026 | 10-Q Nov 3, 2026 | ||
What the company wroteOn September 9, 2026, Alastair Garfield, the Company's Chief Scientific Officer, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 100% of the shares of our common stock issued to Dr. Garfield upon the settlement of outstanding restricted stock units, less the number of shares surrendered to the issuer or sold to cover tax withholding obligations in connection with the vesting and settlement of such restricted stock units, until February 1, 2028. | |||||
| Christophe Jean Director |
Adopted 10b5-1 plan | Aug 18, 2026 | 10-Q Nov 3, 2026 | ||
What the company wroteOn August 18, 2026, Christophe Jean, the Company's Director, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 10,000 shares of the Company's common stock until July 17, 2027. | |||||
| David McGirr Director |
Adopted 10b5-1 plan | Aug 6, 2026 | 10-Q Nov 3, 2026 | ||
What the company wroteOn August 6, 2026, David McGirr, the Company's Director, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 21,810 shares of the Company's common stock until February 7, 2027. | |||||
| Lynn Tetrault member of the Company’s Board of Directors |
Ended 10b5-1 plan | Jun 24, 2026 | 10-Q Aug 4, 2026 | ||
What the company wroteOn June 24, 2026, Lynn Tetrault, a member of the Company’s Board of Directors, terminated a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, which was previously adopted on December 15, 2025 and provided for the sale of up to 55,000 shares of the Company’s common stock until September 16, 2026. | |||||
| David Meeker Company's Chief Executive Officer |
Adopted 10b5-1 plan | Jun 15, 2026 | 10-Q Aug 4, 2026 | ||
What the company wroteOn June 15, 2026, David Meeker, the Company's Chief Executive Officer, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 300,000 shares of the Company's common stock until March 15, 2027. | |||||
| Alastair Garfield Company's Chief Scientific Officer |
Adopted 10b5-1 plan | May 14, 2026 | 10-Q Aug 4, 2026 | ||
What the company wroteOn May 14, 2026, Alastair Garfield, the Company's Chief Scientific Officer, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 7,763 shares of the Company's common stock until February 13, 2027. | |||||
| Jennifer Lee Company's Executive Vice President, Head of North America |
Adopted 10b5-1 plan | May 14, 2026 | 10-Q Aug 4, 2026 | ||
What the company wroteOn May 14, 2026, Jennifer Lee, the Company's Executive Vice President, Head of North America, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 76,201 shares of the Company's common stock as well as up to 100% of the shares of our common stock issued to Ms. Lee upon the settlement of outstanding restricted stock units, less the number of shares surrendered to the issuer or sold to cover tax withholding obligations in connection with the vesting and settlement of such restricted stock units, until March 1, 2027. | |||||
| Hunter Smith Company's Chief Financial Officer |
Adopted 10b5-1 plan | May 13, 2026 | 10-Q Aug 4, 2026 | ||
What the company wroteOn May 13, 2026, Hunter Smith, the Company's Chief Financial Officer, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 62,774 shares of the Company's common stock as well as up to 100% of the shares of our common stock issued to Mr. Smith upon the settlement of outstanding restricted stock units, less the number of shares surrendered to the issuer or sold to cover tax withholding obligations in connection with the vesting and settlement of such restricted stock units, until May 12, 2027. | |||||
| Yann Mazzabraud Company's Executive Vice President, Head of International |
Adopted 10b5-1 plan | May 13, 2026 | 10-Q Aug 4, 2026 | ||
What the company wroteOn May 13, 2026, Yann Mazzabraud, the Company's Executive Vice President, Head of International, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 57,000 shares of the Company's common stock until August 15, 2027. | |||||
| Jennifer Lee Company's EVP, Head of North America |
Adopted 10b5-1 plan | Dec 15, 2025 | 10-K Feb 26, 2026 | ||
What the company wroteOn December 15, 2025, Jennifer Lee, the Company's EVP, Head of North America, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 62,459 shares of the Company's common stock until October 1, 2026. | |||||
| Joseph Shulman Company's Chief Technical Officer |
Adopted 10b5-1 plan | Dec 15, 2025 | 10-K Feb 26, 2026 | ||
What the company wroteOn December 15, 2025, Joseph Shulman, the Company's Chief Technical Officer, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 66,910 shares of the Company's common stock until March 12, 2027. | |||||
| Lynn Tetrault member of the Company's Board of Directors |
Adopted 10b5-1 plan | Dec 15, 2025 | 10-K Feb 26, 2026 | ||
What the company wroteOn December 15, 2025, Lynn Tetrault, a member of the Company's Board of Directors, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 55,000 shares of the Company's common stock until September 16, 2026. | |||||
| Pamela Cramer Company's Chief Human Resources Officer |
Adopted 10b5-1 plan | Dec 15, 2025 | 10-K Feb 26, 2026 | ||
What the company wroteOn December 15, 2025, Pamela Cramer, the Company's Chief Human Resources Officer, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 52,617 shares of the Company's common stock until March 15, 2027. | |||||
| Jennifer Kayden Lee Company’s Executive Vice President, Head of North America |
Adopted 10b5-1 plan | Aug 8, 2025 | 10-Q Nov 4, 2025 | ||
What the company wroteOn August 8, 2025, Jennifer Kayden Lee, the Company’s Executive Vice President, Head of North America, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 62,459 shares of the Company’s common stock as well as up to 100% of the shares of our common stock issued upon the settlement of outstanding restricted stock units, less the number of shares traded to cover tax withholding obligations in connection with the vesting and settlement of such restricted stock units, until June 1, 2026. | |||||
| Pamela Cramer Company’s Chief Human Resources Officer |
Adopted 10b5-1 plan | Aug 7, 2025 | 10-Q Nov 4, 2025 | ||
What the company wroteOn August 7, 2025, Pamela Cramer, the Company’s Chief Human Resources Officer, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 29,566 shares of the Company’s common stock until November 1, 2026. | |||||
| Jennifer Good board of directors |
Ended 10b5-1 plan | May 22, 2025 | 10-Q/A Aug 14, 2024 | ||
| Pamela J. Cramer Chief Human Resources Officer |
Ended 10b5-1 plan | May 15, 2025 | 10-Q/A Aug 14, 2024 | ||
| Christopher German Corporate Controller and Chief Accounting Officer |
Adopted 10b5-1 plan | Mar 11, 2025 | 10-Q May 7, 2025 | ||
What the company wroteOn March 11, 2025, Christopher German, the Company’s Corporate Controller and Chief Accounting Officer, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 7,386 shares of the Company’s common stock until June 10, 2026. | |||||
| David Meeker Chairman, President, and Chief Executive Officer |
Adopted 10b5-1 plan | Mar 3, 2025 | 10-Q May 7, 2025 | ||
What the company wroteOn March 3, 2025, David Meeker, the Company’s Chairman, President, and Chief Executive Officer, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 43,621 shares of the Company’s common stock until November 7, 2025. | |||||
| David McGirr board of directors |
Adopted 10b5-1 plan | Feb 28, 2025 | 10-Q May 7, 2025 | ||
What the company wroteOn February 28, 2025, David McGirr, a member of the Company’s board of directors, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 65,431 shares of the Company’s common stock until November 7, 2025. | |||||
| Hunter Smith Chief Financial Officer |
Adopted 10b5-1 plan | Feb 28, 2025 | 10-Q May 7, 2025 | ||
What the company wroteOn February 28, 2025, Hunter Smith, the Company’s Chief Financial Officer, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 121,185 shares of the Company’s common stock until May 30, 2026. | |||||
| Pamela Cramer Chief Human Resources Officer |
Adopted 10b5-1 plan | Dec 16, 2024 | 10-K Feb 28, 2025 | ||
What the company wroteOn December 16, 2024, Pamela Cramer, the Company’s Chief Human Resources Officer, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 50,394 shares of the Company’s common stock until March 17, 2026. | |||||
| Yann Mazabraud EVP, Head of International |
Adopted 10b5-1 plan | Dec 13, 2024 | 10-K Feb 28, 2025 | ||
What the company wroteOn December 13, 2024, Yann Mazabraud, the Company’s EVP, Head of International, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 99,495 shares of the Company’s common stock until November 11, 2025. | |||||
| Lynn Tetrault board of directors |
Ended 10b5-1 plan | Nov 28, 2024 | 10-Q/A Aug 14, 2024 | ||
| Jennifer Kayden Lee EVP, Head of North America |
Adopted 10b5-1 plan | Aug 8, 2024 | 10-Q Nov 6, 2024 | ||
What the company wroteOn August 8, 2024, Jennifer Kayden Lee, the Company’s EVP, Head of North America, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 71,050 shares of the Company’s common stock until September 1, 2025. | |||||
| Jospeh Shulman Chief Technical Officer |
Adopted 10b5-1 plan | Aug 8, 2024 | 10-Q Nov 6, 2024 | ||
What the company wroteOn August 8, 2024, Jospeh Shulman, the Company’s Chief Technical Officer, adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 73,203 shares of the Company’s common stock until November 5, 2025. | |||||
Show the other 19 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 16 filings checked since May 2, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Sep 14, 2026 | David Meeker Director, Officer |
50,000 | $5.2M |
| Aug 31, 2026 | HUNTER SMITH Officer |
62,774 | $6.7M |
| Aug 13, 2026 | ALASTAIR GARFIELD Officer |
7,763 | $913K |
| Aug 13, 2026 | JOSEPH J SHULMAN Officer |
5,079 | $597K |
| Aug 13, 2026 | Jennifer Kayden Lee Officer |
75,834 | $8.9M |
| Aug 12, 2026 | YANN MAZABRAUD Officer |
57,000 | $6.4M |
| Aug 11, 2026 | PAMELA CRAMER Officer |
11,406 | $1.3M |
| Aug 10, 2026 | PAMELA CRAMER Officer |
3,520 | $407K |
| Jun 22, 2026 | LYNN TETRAULT Director |
37,000 | $3.6M |
| Mar 4, 2026 | CAMILLE L BEDROSIAN Director |
64,540 | $5.8M |
| Mar 3, 2026 | CAMILLE L BEDROSIAN Director |
35,460 | $3.2M |
| Feb 5, 2026 | HUNTER SMITH Officer |
18,406 | $2.0M |
| Feb 4, 2026 | HUNTER SMITH Officer |
3,247 | $352K |
| Dec 11, 2025 | PAMELA CRAMER Officer |
3,350 | $351K |
| Nov 20, 2025 | PAMELA CRAMER Officer |
3,350 | $346K |
Show the other 7 notices
From the Form 144 XML filed with the SEC, since Nov 20, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/RYTM/export.csv") into a cell.